首页 > 最新文献

Obstetrics and Gynecology International最新文献

英文 中文
A Cross-Sectional Analysis of the Incidence of Hydatidiform Mole in Colombia.
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-08 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/8899358
Mario Arturo González Mariño

Objective: To describe the incidence of hydatidiform mole in Colombia. Design: Cross-sectional descriptive study. Setting: Colombia. Population or Sample: The total population at risk of hydatidiform mole (15-49 years old) from 2015 to 2023 was 117.890.729 women. Methods: A search of the national database of the Ministry of Health and Social Protection of Colombia using ICD-10 for hydatidiform mole and ectopic pregnancy was conducted from 2015 to 2023. Incidences were calculated using data from the National Department of Statistics of Colombia. Main Outcome Measures: The incidence of hydatidiform mole was calculated by ratios compared with the live births, the proportion of pregnancies, and the incidence rate in the at-risk population. Results: In the reviewed period, 2247 cases of hydatidiform mole were reported. The proportion of unspecified hydatidiform moles during the evaluation period was 78.59% of the reports, the incidence ratio was one hydatidiform mole for every 2486 live births, the proportion was 37.7 × 105 pregnancies and the cumulative incidence was 1.90 × 105 women of 15-49 years. The age range with the highest number of cases was 20-29 years with 1039 cases. Conclusions: The high proportion of unspecified hydatidiform mole far exceeds the diagnoses of complete and partial hydatidiform mole. The descriptive design of the study does not allow us to determine the causes of these results. Future studies with more complex methodological designs are required to explain these findings.

{"title":"A Cross-Sectional Analysis of the Incidence of Hydatidiform Mole in Colombia.","authors":"Mario Arturo González Mariño","doi":"10.1155/ogi/8899358","DOIUrl":"10.1155/ogi/8899358","url":null,"abstract":"<p><p><b>Objective:</b> To describe the incidence of hydatidiform mole in Colombia. <b>Design:</b> Cross-sectional descriptive study. <b>Setting:</b> Colombia. <b>Population or Sample:</b> The total population at risk of hydatidiform mole (15-49 years old) from 2015 to 2023 was 117.890.729 women. <b>Methods:</b> A search of the national database of the Ministry of Health and Social Protection of Colombia using ICD-10 for hydatidiform mole and ectopic pregnancy was conducted from 2015 to 2023. Incidences were calculated using data from the National Department of Statistics of Colombia. <b>Main Outcome Measures:</b> The incidence of hydatidiform mole was calculated by ratios compared with the live births, the proportion of pregnancies, and the incidence rate in the at-risk population. <b>Results:</b> In the reviewed period, 2247 cases of hydatidiform mole were reported. The proportion of unspecified hydatidiform moles during the evaluation period was 78.59% of the reports, the incidence ratio was one hydatidiform mole for every 2486 live births, the proportion was 37.7 × 10<sup>5</sup> pregnancies and the cumulative incidence was 1.90 × 10<sup>5</sup> women of 15-49 years. The age range with the highest number of cases was 20-29 years with 1039 cases. <b>Conclusions:</b> The high proportion of unspecified hydatidiform mole far exceeds the diagnoses of complete and partial hydatidiform mole. The descriptive design of the study does not allow us to determine the causes of these results. Future studies with more complex methodological designs are required to explain these findings.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"8899358"},"PeriodicalIF":1.6,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11830108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of Episiotomy in Kasr Alainy OBGYN Hospital in Cairo, Egypt: A Cross-Sectional Study.
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-05 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/4044738
Omar Sadek, Nora Fahim, Hana Yehia, Mariam Elmashad, Farah Alaa, Abdulrahman Rakha, Ahmad Khaled, Nadine Sherif

Objective: This study aims to determine the incidence of episiotomy in Kasr Alainy OBGYN Hospital in Cairo, Egypt. The objectives include identifying and examining the reasons behind the notably higher episiotomy rates in this region, and assessing the relevance of general WHO recommendations in lower-middle-income countries. Design: This observational cross-sectional study was conducted between March 1, 2022 and June 30, 2022, to determine the incidence of episiotomy among vaginal deliveries in the hospital. Setting: Data was collected from patient charts at Kasr Alainy OBGYN Hospital in Cairo, Egypt. Patient Sample: The total number of patient charts inspected was 1731, of which 1545 met the inclusion criteria. Methods: Data were manually collected from patient hospital records at the end of each day, and entered into a standardized data-collection form. The data collected was then statistically analyzed using SPSS. Main Outcome Measures: The overall incidence of episiotomy was 64%. Results: When analyzed by gravidity, the incidence was found to be 97% in primigravida patients and 52% in multigravida patients. Additionally, several other associated factors were examined. Conclusions: The incidence of episiotomy at Kasr Alainy OBGYN Hospital surpasses the rate recommended by the WHO. Our observations suggest that the primary contributing factors to this elevated incidence include perineal rigidity, the duration of labor, and local practice standards. Further research is recommended to explore the impact of perineal massage before and during delivery, as well as patients' lifestyle factors, on the necessity for episiotomy.

{"title":"Incidence of Episiotomy in Kasr Alainy OBGYN Hospital in Cairo, Egypt: A Cross-Sectional Study.","authors":"Omar Sadek, Nora Fahim, Hana Yehia, Mariam Elmashad, Farah Alaa, Abdulrahman Rakha, Ahmad Khaled, Nadine Sherif","doi":"10.1155/ogi/4044738","DOIUrl":"10.1155/ogi/4044738","url":null,"abstract":"<p><p><b>Objective:</b> This study aims to determine the incidence of episiotomy in Kasr Alainy OBGYN Hospital in Cairo, Egypt. The objectives include identifying and examining the reasons behind the notably higher episiotomy rates in this region, and assessing the relevance of general WHO recommendations in lower-middle-income countries. <b>Design:</b> This observational cross-sectional study was conducted between March 1, 2022 and June 30, 2022, to determine the incidence of episiotomy among vaginal deliveries in the hospital. <b>Setting:</b> Data was collected from patient charts at Kasr Alainy OBGYN Hospital in Cairo, Egypt. <b>Patient Sample:</b> The total number of patient charts inspected was 1731, of which 1545 met the inclusion criteria. <b>Methods:</b> Data were manually collected from patient hospital records at the end of each day, and entered into a standardized data-collection form. The data collected was then statistically analyzed using SPSS. <b>Main Outcome Measures:</b> The overall incidence of episiotomy was 64%. <b>Results:</b> When analyzed by gravidity, the incidence was found to be 97% in primigravida patients and 52% in multigravida patients. Additionally, several other associated factors were examined. <b>Conclusions:</b> The incidence of episiotomy at Kasr Alainy OBGYN Hospital surpasses the rate recommended by the WHO. Our observations suggest that the primary contributing factors to this elevated incidence include perineal rigidity, the duration of labor, and local practice standards. Further research is recommended to explore the impact of perineal massage before and during delivery, as well as patients' lifestyle factors, on the necessity for episiotomy.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"4044738"},"PeriodicalIF":1.6,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11824849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Age and Body Mass Index on the Outcomes of Laparoscopic Mesh Sacrocolpopexy.
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-16 eCollection Date: 2025-01-01 DOI: 10.1155/ogi/1706041
Nour Khalil, Nadine El Kassis, Malak Moubarak, Christian Chaccour, Samer Maalouf, Elie Nemr, Houssein El Hajj, Maroun Moukarzel, David Atallah

Background: Pelvic organ prolapse (POP) is a benign condition that can adversely affect women's quality of life. Mesh sacrocolpopexy is an effective surgical treatment for POP, but is considered a complex and risky surgery for obese and elderly women. The objective of this study was to assess the impact of age and obesity on the outcomes of minimally invasive sacrocolpopexy. Methods: We performed a retrospective cohort study reviewing all minimally invasive sacrocolpopexy cases performed between 2003 and 2021. Data on operative time, hospital stay, conversion rate, perioperative injuries, early and late postoperative complications were collected. Surgical success was evaluated by gynecological examination at each follow-up visit. Results: One hundred seventy subjects were included, of whom 44% were older than 65 years and 58% had a body mass index (BMI) above 25 kg/m2. Seventy percent presented stage III uterovaginal prolapse. All patients achieved a good subjective outcome with no reported prolapse with a mean follow-up of 6 years. The rate of de novo stress urinary incontinence was 3.2%. Vaginal implant exposure was found in 4% of cases. A bivariate analysis studying the impact of older age (≥ 65 vs. < 65 years) and higher BMI (≥ 25 vs. < 25) on surgical and postoperative outcomes did not show any significant differences between the subgroups (p > 0.05). Conclusion: In experienced hands, laparoscopic sacrocolpopexy can be used as a safe and effective procedure for operable patients with POP, even when patients are between 65 and 80 years or have a BMI of 25 kg/m2 and above.

{"title":"Impact of Age and Body Mass Index on the Outcomes of Laparoscopic Mesh Sacrocolpopexy.","authors":"Nour Khalil, Nadine El Kassis, Malak Moubarak, Christian Chaccour, Samer Maalouf, Elie Nemr, Houssein El Hajj, Maroun Moukarzel, David Atallah","doi":"10.1155/ogi/1706041","DOIUrl":"10.1155/ogi/1706041","url":null,"abstract":"<p><p><b>Background:</b> Pelvic organ prolapse (POP) is a benign condition that can adversely affect women's quality of life. Mesh sacrocolpopexy is an effective surgical treatment for POP, but is considered a complex and risky surgery for obese and elderly women. The objective of this study was to assess the impact of age and obesity on the outcomes of minimally invasive sacrocolpopexy. <b>Methods:</b> We performed a retrospective cohort study reviewing all minimally invasive sacrocolpopexy cases performed between 2003 and 2021. Data on operative time, hospital stay, conversion rate, perioperative injuries, early and late postoperative complications were collected. Surgical success was evaluated by gynecological examination at each follow-up visit. <b>Results:</b> One hundred seventy subjects were included, of whom 44% were older than 65 years and 58% had a body mass index (BMI) above 25 kg/m<sup>2</sup>. Seventy percent presented stage III uterovaginal prolapse. All patients achieved a good subjective outcome with no reported prolapse with a mean follow-up of 6 years. The rate of de novo stress urinary incontinence was 3.2%. Vaginal implant exposure was found in 4% of cases. A bivariate analysis studying the impact of older age (≥ 65 vs. < 65 years) and higher BMI (≥ 25 vs. < 25) on surgical and postoperative outcomes did not show any significant differences between the subgroups (<i>p</i> > 0.05). <b>Conclusion:</b> In experienced hands, laparoscopic sacrocolpopexy can be used as a safe and effective procedure for operable patients with POP, even when patients are between 65 and 80 years or have a BMI of 25 kg/m<sup>2</sup> and above.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"1706041"},"PeriodicalIF":1.6,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11756942/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143047271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cord Blood Platelet-Rich Plasma in Cesarean Section Wound Management. 脐带血富血小板血浆在剖宫产术创面处理中的应用。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-12 eCollection Date: 2024-01-01 DOI: 10.1155/ogi/4155779
Amornrat Thanachaiviwat, Sutham Suthaporn, Patana Teng-Umnuay

Platelet-rich plasma (PRP) promotes the wound-healing process and reduces pain. Cord blood platelet-rich plasma (CB-PRP), which can be easily collected from the umbilical cord and reapplied to a cesarean section wound, has been proposed to have similar effects as PRP. This paper hypothesizes that CB-PRB would provide beneficial effects in terms of wound healing and pain reduction in women undergoing cesarean section. This study is a randomized controlled trial involving 52 pregnant women who underwent cesarean sections. Participants were assigned to either the intervention group (n = 26) or the control group (n = 26) at the Obstetrics and Gynecology Clinic of Police General Hospital. Cord blood PRP was applied to the subcutaneous layer and the surgical wound immediately following the cesarean section. The efficacy of wound healing was evaluated using the REEDA scale score on days 1 and 3 postoperatively, and the Vancouver Scar Scale (VSS) was assessed in the 8th week postoperation. The efficacy in reducing pain was measured using a Visual Analog Scale on days 1 and 3 postoperatively. The mean REEDA scale on day 1 (mean ± SD: 1.5 ± 0.2561.5 ± 0.256 in the CB-PRP group and 2.5 ± 0.267 in the control group; p=0.009) and the mean VSS score at the 8th week (mean ± SD: 2.577 ± 2.003 in the CB-PRP group and 6.962 ± 2.441 in the control group; p < 0.001) were significantly lower in the CB-PRP group than those in the control group. However, there were no differences in Visual Analog Scale values between the two groups. The findings indicate that CB-PRP potentially promotes wound healing following cesarean sections but does not reduce pain. Further research is needed to confirm the beneficial effects of CB-PRP.

富血小板血浆(PRP)促进伤口愈合过程,减轻疼痛。脐带血富血小板血浆(CB-PRP)可以很容易地从脐带中收集并重新应用于剖宫产伤口,已被认为具有与PRP相似的效果。本文假设CB-PRB在剖宫产术中伤口愈合和疼痛减轻方面具有有益作用。本研究是一项随机对照试验,涉及52名接受剖宫产手术的孕妇。在警察总医院妇产科门诊,将参与者分为干预组(n = 26)和对照组(n = 26)。剖宫产后立即将脐带血PRP应用于皮下层和手术伤口。术后第1天、第3天采用REEDA量表评分评估创面愈合效果,第8周采用温哥华疤痕量表(Vancouver Scar scale, VSS)评估创面愈合效果。术后第1天和第3天采用视觉模拟量表测量疼痛减轻效果。第1天平均REEDA评分(平均±SD: CB-PRP组1.5±0.2561.5±0.256,对照组2.5±0.267;p=0.009)和第8周VSS平均评分(平均±SD: CB-PRP组为2.577±2.003,对照组为6.962±2.441;p < 0.001), CB-PRP组显著低于对照组。然而,两组之间的视觉模拟量表值没有差异。研究结果表明,CB-PRP可能促进剖宫产术后伤口愈合,但不能减轻疼痛。需要进一步的研究来证实CB-PRP的有益作用。
{"title":"Cord Blood Platelet-Rich Plasma in Cesarean Section Wound Management.","authors":"Amornrat Thanachaiviwat, Sutham Suthaporn, Patana Teng-Umnuay","doi":"10.1155/ogi/4155779","DOIUrl":"10.1155/ogi/4155779","url":null,"abstract":"<p><p>Platelet-rich plasma (PRP) promotes the wound-healing process and reduces pain. Cord blood platelet-rich plasma (CB-PRP), which can be easily collected from the umbilical cord and reapplied to a cesarean section wound, has been proposed to have similar effects as PRP. This paper hypothesizes that CB-PRB would provide beneficial effects in terms of wound healing and pain reduction in women undergoing cesarean section. This study is a randomized controlled trial involving 52 pregnant women who underwent cesarean sections. Participants were assigned to either the intervention group (<i>n</i> = 26) or the control group (<i>n</i> = 26) at the Obstetrics and Gynecology Clinic of Police General Hospital. Cord blood PRP was applied to the subcutaneous layer and the surgical wound immediately following the cesarean section. The efficacy of wound healing was evaluated using the REEDA scale score on days 1 and 3 postoperatively, and the Vancouver Scar Scale (VSS) was assessed in the 8th week postoperation. The efficacy in reducing pain was measured using a Visual Analog Scale on days 1 and 3 postoperatively. The mean REEDA scale on day 1 (mean ± SD: 1.5 ± 0.2561.5 ± 0.256 in the CB-PRP group and 2.5 ± 0.267 in the control group; <i>p</i>=0.009) and the mean VSS score at the 8th week (mean ± SD: 2.577 ± 2.003 in the CB-PRP group and 6.962 ± 2.441 in the control group; <i>p</i> < 0.001) were significantly lower in the CB-PRP group than those in the control group. However, there were no differences in Visual Analog Scale values between the two groups. The findings indicate that CB-PRP potentially promotes wound healing following cesarean sections but does not reduce pain. Further research is needed to confirm the beneficial effects of CB-PRP.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2024 ","pages":"4155779"},"PeriodicalIF":1.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11658848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142864976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 and Pregnancy Outcomes: A Descriptive Study From a Tertiary Hospital in Ras Al Khaimah, UAE. COVID-19与妊娠结局:来自阿联酋哈伊马角一家三级医院的描述性研究
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-03 eCollection Date: 2024-01-01 DOI: 10.1155/ogi/5252919
Manal M Sami, Shatha Al Zuheiri, Nour K Sabaneh, Mustafa Amir Abdul Latif, Shooq Yousef Al-Blooshi, Mira Osman

Background: Over 768 million cases of COVID-19 infection have been reported worldwide, with pregnant women being the most vulnerable members of society during such an infectious disease outbreak. In the United Arab Emirates, there are limited studies explaining the effects of COVID-19 on pregnant women and their fetuses. In this study, the maternal and fetal outcomes in pregnant women with COVID-19 in a tertiary maternal hospital, United Arab Emirates, were examined. Materials and Methods: A descriptive study was conducted in a tertiary hospital for Obstetrics and Gynecology in Ras Al Khaimah, UAE. The study included all pregnant women who tested positive for COVID-19 infection from April 2020 to September 2021. Results: The study revealed that a higher number of COVID-19-infected pregnant patients presented in their third trimester (69.1%). The comorbidity of body mass index (BMI) had the most effect on the severity/hospitalization status of the patients (p=0.018). In the nonhospitalized group, fever was the most common symptom (26%), whereas in the hospitalized group, cough was the most common symptom (94%). Emergency cesarean delivery was found to be significant (p=0.0007) in hospitalized patients. COVID-19 pneumonia was the prevailing adverse maternal outcome. NICU admission and prematurity were the most frequent neonatal outcomes. Conclusions: In conclusion, our findings show that adverse maternal outcomes, obesity, and mode of delivery were related to COVID-19 severity in pregnant patients. However, there was no effect generally on the adverse fetal outcomes except for jaundice and birth weight.

背景:全世界已经报告了超过7.68亿例COVID-19感染病例,在这种传染病爆发期间,孕妇是社会中最脆弱的成员。在阿拉伯联合酋长国,解释COVID-19对孕妇及其胎儿影响的研究有限。本研究对阿拉伯联合酋长国一家三级妇产医院感染COVID-19的孕妇的母胎结局进行了检查。材料和方法:在阿联酋哈伊马角的一家三级妇产科医院进行了一项描述性研究。该研究包括2020年4月至2021年9月期间所有COVID-19感染检测呈阳性的孕妇。结果:研究发现,感染新冠病毒的孕妇在妊娠晚期出现的比例较高(69.1%)。体重指数(BMI)的合并症对患者的严重程度/住院状况影响最大(p=0.018)。在未住院组中,发烧是最常见的症状(26%),而在住院组中,咳嗽是最常见的症状(94%)。急诊剖宫产在住院患者中有显著性意义(p=0.0007)。COVID-19肺炎是主要的不良产妇结局。新生儿入院和早产是最常见的新生儿结局。结论:总之,我们的研究结果表明,孕妇的不良结局、肥胖和分娩方式与COVID-19严重程度有关。然而,除了黄疸和出生体重外,对胎儿的不良结局一般没有影响。
{"title":"COVID-19 and Pregnancy Outcomes: A Descriptive Study From a Tertiary Hospital in Ras Al Khaimah, UAE.","authors":"Manal M Sami, Shatha Al Zuheiri, Nour K Sabaneh, Mustafa Amir Abdul Latif, Shooq Yousef Al-Blooshi, Mira Osman","doi":"10.1155/ogi/5252919","DOIUrl":"10.1155/ogi/5252919","url":null,"abstract":"<p><p><b>Background:</b> Over 768 million cases of COVID-19 infection have been reported worldwide, with pregnant women being the most vulnerable members of society during such an infectious disease outbreak. In the United Arab Emirates, there are limited studies explaining the effects of COVID-19 on pregnant women and their fetuses. In this study, the maternal and fetal outcomes in pregnant women with COVID-19 in a tertiary maternal hospital, United Arab Emirates, were examined. <b>Materials and Methods:</b> A descriptive study was conducted in a tertiary hospital for Obstetrics and Gynecology in Ras Al Khaimah, UAE. The study included all pregnant women who tested positive for COVID-19 infection from April 2020 to September 2021. <b>Results:</b> The study revealed that a higher number of COVID-19-infected pregnant patients presented in their third trimester (69.1%). The comorbidity of body mass index (BMI) had the most effect on the severity/hospitalization status of the patients (<i>p</i>=0.018). In the nonhospitalized group, fever was the most common symptom (26%), whereas in the hospitalized group, cough was the most common symptom (94%). Emergency cesarean delivery was found to be significant (<i>p</i>=0.0007) in hospitalized patients. COVID-19 pneumonia was the prevailing adverse maternal outcome. NICU admission and prematurity were the most frequent neonatal outcomes. <b>Conclusions:</b> In conclusion, our findings show that adverse maternal outcomes, obesity, and mode of delivery were related to COVID-19 severity in pregnant patients. However, there was no effect generally on the adverse fetal outcomes except for jaundice and birth weight.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2024 ","pages":"5252919"},"PeriodicalIF":1.6,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11631290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BRCA1 Protein Expression in Epithelial Ovarian Cancer and Associated Clinicopathological Factors in Uganda. 乌干达上皮性卵巢癌中的 BRCA1 蛋白表达及相关临床病理因素。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9527113
Tonny Okecha, Derrick B Abila, Dorothy L Nabbale, Fauz Katongole, James J Yahaya, Robert Lukande, Sam Kalungi, Hawa Nalwoga

Background: BRCA1 gene dysfunction seen in epithelial ovarian carcinomas often results from germline mutations, somatic mutations, and promoter methylation. Identification of tumors with loss of BRCA1 protein expression has shown to have therapeutic and prognostic implications. The aim of this study was to determine the expression of BRCA1 protein in epithelial ovarian cancer (EOC) and the associated clinicopathological characteristics. Methods and Results: This was a cross-sectional laboratory-based study that used paraffin-embedded tissue blocks of patients histologically diagnosed with EOC from January 2010 to August 2018. Tissue sections were stained with hematoxylin and eosin (H&E) for histological confirmation and with immunohistochemistry (IHC) using a mouse-derived monoclonal antibody MS110 for BRCA1 protein expression. The association between BRCA1 protein expression and independent variables was determined using Pearson's Chi-square test. A total of 104 tissue blocks from patients with EOC were included in the study with a mean age of 48.7 ± 12.8 years. Serous tumors were the most common which comprised 74.0% (77/104) of all the tumors and majority of them 75.3% (58/77) were high grade. Loss of expression of BRCA1 protein expression was found in 33.7% (33/98) of all the cases. There was no statistically significant association between BRCA1 expression and age of patients, tumor grade, and histological subtype. Conclusion: There is a high expression of altered BRCA1 expression in tissues of EOC. Although it has not shown association with age of patients, histology types, and tumor grade, further studies need to assess its influence of the survival of cancer patients with EOC.

背景:上皮性卵巢癌中的 BRCA1 基因功能失调通常是由种系突变、体细胞突变和启动子甲基化引起的。对 BRCA1 蛋白表达缺失的肿瘤进行鉴定具有治疗和预后意义。本研究旨在确定上皮性卵巢癌(EOC)中 BRCA1 蛋白的表达及其相关的临床病理特征。方法和结果:这是一项基于实验室的横断面研究,采用了2010年1月至2018年8月期间经组织学诊断为EOC患者的石蜡包埋组织块。组织切片经苏木精和伊红(H&E)染色进行组织学确认,并使用鼠源单克隆抗体 MS110 进行免疫组化(IHC)检测 BRCA1 蛋白表达。BRCA1 蛋白表达与自变量之间的关系采用皮尔逊卡方检验(Pearson's Chi-square test)确定。研究共纳入了104个EOC患者的组织块,平均年龄为(48.7 ± 12.8)岁。浆液性肿瘤最常见,占所有肿瘤的74.0%(77/104),其中75.3%(58/77)为高级别肿瘤。33.7%的病例(33/98)发现 BRCA1 蛋白表达缺失。BRCA1 表达与患者年龄、肿瘤分级和组织学亚型之间没有统计学意义上的关联。结论在 EOC 组织中,BRCA1 表达改变的比例很高。虽然它与患者年龄、组织学类型和肿瘤分级没有关联,但仍需进一步研究其对 EOC 癌症患者生存期的影响。
{"title":"<i>BRCA1</i> Protein Expression in Epithelial Ovarian Cancer and Associated Clinicopathological Factors in Uganda.","authors":"Tonny Okecha, Derrick B Abila, Dorothy L Nabbale, Fauz Katongole, James J Yahaya, Robert Lukande, Sam Kalungi, Hawa Nalwoga","doi":"10.1155/2024/9527113","DOIUrl":"10.1155/2024/9527113","url":null,"abstract":"<p><p><b>Background:</b> <i>BRCA1</i> gene dysfunction seen in epithelial ovarian carcinomas often results from germline mutations, somatic mutations, and promoter methylation. Identification of tumors with loss of <i>BRCA1</i> protein expression has shown to have therapeutic and prognostic implications. The aim of this study was to determine the expression of <i>BRCA1</i> protein in epithelial ovarian cancer (EOC) and the associated clinicopathological characteristics. <b>Methods and Results:</b> This was a cross-sectional laboratory-based study that used paraffin-embedded tissue blocks of patients histologically diagnosed with EOC from January 2010 to August 2018. Tissue sections were stained with hematoxylin and eosin (H&E) for histological confirmation and with immunohistochemistry (IHC) using a mouse-derived monoclonal antibody MS110 for <i>BRCA1</i> protein expression. The association between <i>BRCA1</i> protein expression and independent variables was determined using Pearson's Chi-square test. A total of 104 tissue blocks from patients with EOC were included in the study with a mean age of 48.7 ± 12.8 years. Serous tumors were the most common which comprised 74.0% (77/104) of all the tumors and majority of them 75.3% (58/77) were high grade. Loss of expression of <i>BRCA1</i> protein expression was found in 33.7% (33/98) of all the cases. There was no statistically significant association between <i>BRCA1</i> expression and age of patients, tumor grade, and histological subtype. <b>Conclusion:</b> There is a high expression of altered <i>BRCA1</i> expression in tissues of EOC. Although it has not shown association with age of patients, histology types, and tumor grade, further studies need to assess its influence of the survival of cancer patients with EOC.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2024 ","pages":"9527113"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of "Motivational Interviewing" and "Information, Motivation, and Behavioral Skills Model" Counseling Interventions on the Choice of Delivery Mode in Pregnant Women Using Face-to-Face Training vs. Mobile App: A Randomized Controlled Trial. 动机访谈 "和 "信息、动机和行为技能模型 "咨询干预对孕妇分娩方式选择的影响:面对面培训与移动应用程序:随机对照试验
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-30 eCollection Date: 2024-01-01 DOI: 10.1155/2024/3071183
Mahboubeh Shirzad, Elham Shakibazadeh, Payam Sheikhatari, Abbas Rahimi Foroushani, Hamid Poursharifi

Objective: To investigate the impact of counseling interventions, using face-to-face training vs. mobile app for choosing mode of delivery.

Design: A four-armed, randomized, controlled parallel-design trial. Setting. Ebnesina Private Hospital in Tehran, Iran. Population. Pregnant women, between 24 and 32 weeks of gestation (n = 120).

Methods: Pregnant women were randomly assigned in three psycho-educational intervention groups: (1) motivational interviewing via face-to-face training, (2) information, motivation, and behavioral skills model via face-to-face training, (3) the same model via a mobile application, and (4) usual antenatal care (control group). To assess the face-to-face and mobile app training method on women's self-efficacy and intention in choosing a mode of delivery. Main Outcome Measures. Mode of delivery (Cesarean section).

Results: While all three intervention groups showed significant increases in women's self-efficacy and intentions to choose vaginal delivery, the increase was particularly noticeable among those using mobile applications: Before the intervention, self-efficacy and intention Mean ± SD were 77.1 ± 38.6 (CI-95%: [62.72, 91.60]) and 1.10 ± 0.305 (CI-95%: [0.99, 1.21]), respectively. After the intervention, these scores increased to 99.7 ± 30.7 (CI-95%: [88.27, 111.20]) for self-efficacy and 1.70 ± 0.466 (CI-95%: [1.53, 1.87]) for intention. Although 56.7% of women in the intervention groups expressed a preference for vaginal delivery, only 37.5% ultimately pursued this birthing method.

Conclusions: Brief psycho-educational interventions, particularly technology-driven interventions (mobile apps) can increase the likelihood of women choosing vaginal delivery. To enhance the effectiveness of such interventions, they can be conducted in conjunction with interventions for doctors and healthcare providers. This trial is registered with IRCT20151208025431N7.

目的调查咨询干预措施的影响,选择面对面培训与手机应用程序的授课方式:设计:四臂随机对照平行设计试验。地点:德黑兰 Ebnesina 私立医院伊朗德黑兰 Ebnesina 私人医院。人群妊娠 24 至 32 周的孕妇(n = 120):孕妇被随机分配到三个心理教育干预组:(1)通过面对面培训进行动机访谈;(2)通过面对面培训进行信息、动机和行为技能模式;(3)通过移动应用程序进行相同模式;(4)常规产前护理(对照组)。评估面对面培训和手机应用培训方法对产妇选择分娩方式的自我效能感和意向的影响。主要结果指标。分娩方式(剖腹产):所有三个干预组的妇女在选择阴道分娩的自我效能感和意向方面都有显著提高,而使用移动应用程序的妇女的提高尤为明显:干预前,自我效能和意向平均值(± SD)分别为 77.1 ± 38.6(CI-95%:[62.72, 91.60])和 1.10 ± 0.305(CI-95%:[0.99, 1.21])。干预后,自我效能感得分增至 99.7 ± 30.7 (CI-95%: [88.27, 111.20]),意向得分增至 1.70 ± 0.466 (CI-95%: [1.53, 1.87])。虽然干预组中有 56.7% 的妇女表示倾向于阴道分娩,但只有 37.5% 的妇女最终选择了这种分娩方式:结论:简短的心理教育干预,尤其是技术驱动的干预(手机应用)可以增加产妇选择阴道分娩的可能性。为提高此类干预措施的效果,可将其与针对医生和医疗服务提供者的干预措施结合起来进行。本试验已注册为 IRCT20151208025431N7。
{"title":"The Effect of \"Motivational Interviewing\" and \"Information, Motivation, and Behavioral Skills Model\" Counseling Interventions on the Choice of Delivery Mode in Pregnant Women Using Face-to-Face Training vs. Mobile App: A Randomized Controlled Trial.","authors":"Mahboubeh Shirzad, Elham Shakibazadeh, Payam Sheikhatari, Abbas Rahimi Foroushani, Hamid Poursharifi","doi":"10.1155/2024/3071183","DOIUrl":"https://doi.org/10.1155/2024/3071183","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the impact of counseling interventions, using face-to-face training vs. mobile app for choosing mode of delivery.</p><p><strong>Design: </strong>A four-armed, randomized, controlled parallel-design trial. <i>Setting</i>. Ebnesina Private Hospital in Tehran, Iran. <i>Population</i>. Pregnant women, between 24 and 32 weeks of gestation (<i>n</i> = 120).</p><p><strong>Methods: </strong>Pregnant women were randomly assigned in three psycho-educational intervention groups: (1) motivational interviewing via face-to-face training, (2) information, motivation, and behavioral skills model via face-to-face training, (3) the same model via a mobile application, and (4) usual antenatal care (control group). To assess the face-to-face and mobile app training method on women's self-efficacy and intention in choosing a mode of delivery. <i>Main Outcome Measures</i>. Mode of delivery (Cesarean section).</p><p><strong>Results: </strong>While all three intervention groups showed significant increases in women's self-efficacy and intentions to choose vaginal delivery, the increase was particularly noticeable among those using mobile applications: Before the intervention, self-efficacy and intention Mean ± SD were 77.1 ± 38.6 (CI-95%: [62.72, 91.60]) and 1.10 ± 0.305 (CI-95%: [0.99, 1.21]), respectively. After the intervention, these scores increased to 99.7 ± 30.7 (CI-95%: [88.27, 111.20]) for self-efficacy and 1.70 ± 0.466 (CI-95%: [1.53, 1.87]) for intention. Although 56.7% of women in the intervention groups expressed a preference for vaginal delivery, only 37.5% ultimately pursued this birthing method.</p><p><strong>Conclusions: </strong>Brief psycho-educational interventions, particularly technology-driven interventions (mobile apps) can increase the likelihood of women choosing vaginal delivery. To enhance the effectiveness of such interventions, they can be conducted in conjunction with interventions for doctors and healthcare providers. This trial is registered with IRCT20151208025431N7.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2024 ","pages":"3071183"},"PeriodicalIF":1.6,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Influencing Induction of Labor Success in Riyadh, Saudi Arabia. 影响沙特阿拉伯利雅得引产成功的因素。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-26 eCollection Date: 2024-01-01 DOI: 10.1155/2024/1637424
Renad A Alshalan, Rwan K Alarfaj, Yazeed A Almojel, Yara AlHaddad, Rahaf Alsomali, Maysoon Al Adham

Introduction: The physiological process by which the fetus and placenta are delivered from the uterus and pass through the vaginal canal for delivery is known as labor. Induction of labor involves deliberately initiating labor before it occurs naturally, using medical interventions or techniques to stimulate contractions and initiate the birthing process.

Aim: This study aimed to investigate the factors that influence the success of labor induction procedures in Riyadh, Saudi Arabia, from January to April 2023. Subject and Methods. This retrospective chart review was conducted at the National Guard Hospital in Riyadh, Saudi Arabia. Data were collected from the patient chart of those who underwent labor induction from January to April 2023. The collected data were tabulated and cleaned in MS Excel. Final data were transferred to SPSS for subsequent data analysis.

Results: Five hundred and thirty-one pregnant women were analyzed. 52.7% were aged 30 years or below. The most common indication of IOL was post-dated pregnancy (26.2%). 62% were normal deliveries, indicative of IOL success, while 31.1% were cesarean deliveries, indicative of IOL failure. In univariate analysis, women with lower gravidity (≤3) and who had received Propess were associated with cesarean delivery. In a multivariate regression analysis, women who received Prostin and increased parity were identified as the significant independent predictors of IOL success.

Conclusion: IOL's success was dependent primarily on increasing parity and Prostin administration. However, lower gravidity (≤3) and Propess medication could lead to operative procedures among pregnant women. Hence, it is necessary to carefully assess the condition of pregnant women before directing them to IOL.

导言:胎儿和胎盘从子宫娩出并通过阴道分娩的生理过程称为分娩。引产是指在自然分娩之前故意启动分娩,使用医疗干预措施或技术刺激子宫收缩并启动分娩过程。研究对象和方法。这项回顾性病历审查在沙特阿拉伯利雅得国民卫队医院进行。数据来自 2023 年 1 月至 4 月期间接受引产手术的患者病历。收集到的数据在 MS Excel 中进行制表和清理。最终数据转入 SPSS 进行后续数据分析:对 531 名孕妇进行了分析。52.7%的孕妇年龄在 30 岁或以下。最常见的人工晶体植入指征是过期妊娠(26.2%)。正常分娩占 62%,表明人工晶体植入术成功,而剖宫产占 31.1%,表明人工晶体植入术失败。在单变量分析中,孕酮较低(≤3)和接受过 Propess 的妇女与剖宫产有关。在多变量回归分析中,接受过前列腺素治疗的产妇和胎次增加被认为是人工晶体植入术成功的重要独立预测因素:结论:人工晶体植入术的成功与否主要取决于胎次的增加和前列腺素的使用。结论:人工晶体植入术的成功与否主要取决于胎次的增加和前列腺素的使用,但胎次较低(≤3)和前列腺素的使用可能导致孕妇进行手术。因此,在指导孕妇使用人工晶体前,有必要仔细评估她们的情况。
{"title":"Factors Influencing Induction of Labor Success in Riyadh, Saudi Arabia.","authors":"Renad A Alshalan, Rwan K Alarfaj, Yazeed A Almojel, Yara AlHaddad, Rahaf Alsomali, Maysoon Al Adham","doi":"10.1155/2024/1637424","DOIUrl":"10.1155/2024/1637424","url":null,"abstract":"<p><strong>Introduction: </strong>The physiological process by which the fetus and placenta are delivered from the uterus and pass through the vaginal canal for delivery is known as labor. Induction of labor involves deliberately initiating labor before it occurs naturally, using medical interventions or techniques to stimulate contractions and initiate the birthing process.</p><p><strong>Aim: </strong>This study aimed to investigate the factors that influence the success of labor induction procedures in Riyadh, Saudi Arabia, from January to April 2023. <i>Subject and Methods</i>. This retrospective chart review was conducted at the National Guard Hospital in Riyadh, Saudi Arabia. Data were collected from the patient chart of those who underwent labor induction from January to April 2023. The collected data were tabulated and cleaned in MS Excel. Final data were transferred to SPSS for subsequent data analysis.</p><p><strong>Results: </strong>Five hundred and thirty-one pregnant women were analyzed. 52.7% were aged 30 years or below. The most common indication of IOL was post-dated pregnancy (26.2%). 62% were normal deliveries, indicative of IOL success, while 31.1% were cesarean deliveries, indicative of IOL failure. In univariate analysis, women with lower gravidity (≤3) and who had received Propess were associated with cesarean delivery. In a multivariate regression analysis, women who received Prostin and increased parity were identified as the significant independent predictors of IOL success.</p><p><strong>Conclusion: </strong>IOL's success was dependent primarily on increasing parity and Prostin administration. However, lower gravidity (≤3) and Propess medication could lead to operative procedures among pregnant women. Hence, it is necessary to carefully assess the condition of pregnant women before directing them to IOL.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2024 ","pages":"1637424"},"PeriodicalIF":1.6,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of COVID-19 Vaccine Impact on Women's Menstrual Health within an 18-Month Follow-Up. 评估 COVID-19 疫苗在 18 个月随访期间对妇女月经健康的影响。
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-26 eCollection Date: 2024-01-01 DOI: 10.1155/2024/7344506
Mona Sadat Larijani, Sana Eybpoosh, Delaram Doroud, Anahita Bavand, Ladan Moradi, Fatemeh Ashrafian, Parinaz Tajmehrabi Namini, Mahsan Zali, Amitis Ramezani

Considering menstruation as a crucial factor in females' health and fertility, any factor that could change its cycle is important. This study was conducted from April 2021 to October 2022 on females who got 3 doses of vaccines against SARS-CoV-2 through different platforms. The participants were requested to provide the trained experts with any changes regarding menstrual cycles after each dose of the vaccine up to 6 months after the booster shots. The disturbances related to the vaccines were identified by the adverse events committee to find possible associations with the applied vaccines. Of 308 women who participated until the end of the study, 22 (7.1%) complained about at least one abnormality in their menstrual patterns. The most common disturbance was metrorrhagia as 10 (48%) incidences followed by menorrhagia as 6 events (24.2%). Notably, the identified complaints were persistent in 59% of the patients. In addition, 14 studied cases developed COVID-19 infection after menstrual disorders. In these cases, COVID-19 could also play a role in the persistence of postvaccine menstrual disturbances. COVID-19 vaccination could affect menstrual cycle in women with no remarkable previous medical history. More longitudinal studies are required regarding this issue.

考虑到月经是女性健康和生育的关键因素,任何可能改变其周期的因素都很重要。这项研究于 2021 年 4 月至 2022 年 10 月进行,对象是通过不同平台接种了 3 剂 SARS-CoV-2 疫苗的女性。参与者需要向经过培训的专家提供每次接种疫苗后至加强注射后 6 个月内月经周期的任何变化。不良事件委员会对与疫苗有关的异常情况进行了鉴定,以找到与所使用疫苗可能存在的关联。在 308 名参与研究直至研究结束的妇女中,有 22 人(7.1%)抱怨她们的月经模式至少出现过一次异常。最常见的月经紊乱是月经过多,有 10 例(48%),其次是月经过多,有 6 例(24.2%)。值得注意的是,59% 的患者的症状持续存在。此外,有 14 例患者在月经紊乱后感染了 COVID-19。在这些病例中,COVID-19 也可能是造成疫苗接种后月经紊乱持续存在的原因之一。接种 COVID-19 疫苗可能会影响既往无明显病史的妇女的月经周期。关于这个问题,需要进行更多的纵向研究。
{"title":"Assessment of COVID-19 Vaccine Impact on Women's Menstrual Health within an 18-Month Follow-Up.","authors":"Mona Sadat Larijani, Sana Eybpoosh, Delaram Doroud, Anahita Bavand, Ladan Moradi, Fatemeh Ashrafian, Parinaz Tajmehrabi Namini, Mahsan Zali, Amitis Ramezani","doi":"10.1155/2024/7344506","DOIUrl":"10.1155/2024/7344506","url":null,"abstract":"<p><p>Considering menstruation as a crucial factor in females' health and fertility, any factor that could change its cycle is important. This study was conducted from April 2021 to October 2022 on females who got 3 doses of vaccines against SARS-CoV-2 through different platforms. The participants were requested to provide the trained experts with any changes regarding menstrual cycles after each dose of the vaccine up to 6 months after the booster shots. The disturbances related to the vaccines were identified by the adverse events committee to find possible associations with the applied vaccines. Of 308 women who participated until the end of the study, 22 (7.1%) complained about at least one abnormality in their menstrual patterns. The most common disturbance was metrorrhagia as 10 (48%) incidences followed by menorrhagia as 6 events (24.2%). Notably, the identified complaints were persistent in 59% of the patients. In addition, 14 studied cases developed COVID-19 infection after menstrual disorders. In these cases, COVID-19 could also play a role in the persistence of postvaccine menstrual disturbances. COVID-19 vaccination could affect menstrual cycle in women with no remarkable previous medical history. More longitudinal studies are required regarding this issue.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2024 ","pages":"7344506"},"PeriodicalIF":1.6,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Hormonal Contraceptives with Depression among Women in Reproductive Age Groups: A Cross-Sectional Analytic Study. 生殖年龄组女性荷尔蒙避孕药与抑郁症的关系:一项横断面分析研究
IF 1.6 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-20 eCollection Date: 2024-01-01 DOI: 10.1155/2024/7309041
Sadia Sultan, Md Abu Bashar, Rahma M Bazhair, Doaa O Abdurahman, Renad A Alrehaili, Meimouna E Ennahoui, Yasmeen S Alsulaiman, Seba D Alamri, Elgawhara F A Mohamed

Introduction: Hormonal contraceptives (HCs) are used for birth control, menstrual disturbances, and premenopausal syndrome. Most women stop using hormonal contraceptives due to changes in their mood. The evidence regarding the association of hormonal contraception with depression shows mixed results. Therefore, we aim to establish the association between the use of hormonal contraception and depressive symptoms.

Methods: A cross-sectional study was conducted on 326 women of the reproductive age group (15-49 years) attending the family planning unit of the obstetrics and gynecology department of a medical college in Saudi Arabia. Their sociodemographic and medical details along with the current use of any contraceptives (hormonal, nonhormonal, or not using any) with duration were collected. Beck depression inventory-II (BDI-II) was applied to the women to assess for depression along with its severity, and a BDI score of >16 was taken to denote clinical depression. Women were stratified by type of contraceptive used, and its association with depression category was assessed.

Results: A total of 326 consenting eligible women in the age group of 15-49 years were enrolled in the study of which 165 (50.6%) were currently using a hormonal contraceptive and 49 (15.0%) were using a nonhormonal contraceptive and the rest 112 (34.4%) were not using any contraceptives. There was no significant difference in the mean BDI scores (p=0.79) and degrees of depression (p=0.06) between the HC users and HC nonusers. However, individual symptoms of depression such as sadness (p=0.01), reduced libido (p=0.0002), feelings of pessimism (p=0.02), and failure (p=0.003) were found to be significantly higher in the HC users than non-HC users.

Conclusion: We conclude that there was no significant difference in mean depression scores between groups. However, a few individual symptoms of depression were high in HC users suggesting depression as a potential side effect of hormonal contraceptive use.

导言:荷尔蒙避孕药(HCs)用于节育、月经紊乱和绝经前综合征。大多数女性因情绪变化而停止使用激素避孕药。荷尔蒙避孕药与抑郁症的关系证据不一。因此,我们旨在确定使用激素避孕药与抑郁症状之间的关联:我们对沙特阿拉伯一所医学院妇产科计划生育科的 326 名育龄妇女(15-49 岁)进行了横断面研究。研究收集了她们的社会人口学和医疗详情,以及目前使用任何避孕药具(激素、非激素或未使用任何避孕药具)的情况和持续时间。对妇女采用贝克抑郁量表-II(BDI-II)评估抑郁及其严重程度,BDI 得分大于 16 分表示临床抑郁。根据使用的避孕药类型对妇女进行分层,并评估其与抑郁类别的关系:共有 326 名年龄介于 15-49 岁之间的符合条件的女性参与了研究,其中 165 人(50.6%)目前正在使用激素避孕药,49 人(15.0%)正在使用非激素避孕药,其余 112 人(34.4%)未使用任何避孕药具。在 BDI 平均得分(P=0.79)和抑郁程度(P=0.06)方面,使用 HC 和不使用 HC 的人没有明显差异。然而,我们发现使用 HC 者的个别抑郁症状,如悲伤(p=0.01)、性欲减退(p=0.0002)、悲观(p=0.02)和失败(p=0.003)明显高于未使用 HC 者:我们得出的结论是,各组之间的平均抑郁评分没有明显差异。结论:我们得出的结论是,各组间的平均抑郁评分无明显差异,但 HC 使用者的个别抑郁症状较高,这表明抑郁是使用激素避孕药的潜在副作用。
{"title":"Association of Hormonal Contraceptives with Depression among Women in Reproductive Age Groups: A Cross-Sectional Analytic Study.","authors":"Sadia Sultan, Md Abu Bashar, Rahma M Bazhair, Doaa O Abdurahman, Renad A Alrehaili, Meimouna E Ennahoui, Yasmeen S Alsulaiman, Seba D Alamri, Elgawhara F A Mohamed","doi":"10.1155/2024/7309041","DOIUrl":"https://doi.org/10.1155/2024/7309041","url":null,"abstract":"<p><strong>Introduction: </strong>Hormonal contraceptives (HCs) are used for birth control, menstrual disturbances, and premenopausal syndrome. Most women stop using hormonal contraceptives due to changes in their mood. The evidence regarding the association of hormonal contraception with depression shows mixed results. Therefore, we aim to establish the association between the use of hormonal contraception and depressive symptoms.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on 326 women of the reproductive age group (15-49 years) attending the family planning unit of the obstetrics and gynecology department of a medical college in Saudi Arabia. Their sociodemographic and medical details along with the current use of any contraceptives (hormonal, nonhormonal, or not using any) with duration were collected. Beck depression inventory-II (BDI-II) was applied to the women to assess for depression along with its severity, and a BDI score of >16 was taken to denote clinical depression. Women were stratified by type of contraceptive used, and its association with depression category was assessed.</p><p><strong>Results: </strong>A total of 326 consenting eligible women in the age group of 15-49 years were enrolled in the study of which 165 (50.6%) were currently using a hormonal contraceptive and 49 (15.0%) were using a nonhormonal contraceptive and the rest 112 (34.4%) were not using any contraceptives. There was no significant difference in the mean BDI scores (<i>p</i>=0.79) and degrees of depression (<i>p</i>=0.06) between the HC users and HC nonusers. However, individual symptoms of depression such as sadness (<i>p</i>=0.01), reduced libido (<i>p</i>=0.0002), feelings of pessimism (<i>p</i>=0.02), and failure (<i>p</i>=0.003) were found to be significantly higher in the HC users than non-HC users.</p><p><strong>Conclusion: </strong>We conclude that there was no significant difference in mean depression scores between groups. However, a few individual symptoms of depression were high in HC users suggesting depression as a potential side effect of hormonal contraceptive use.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2024 ","pages":"7309041"},"PeriodicalIF":1.6,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11436269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obstetrics and Gynecology International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1